详细说明
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-PLGL-Dpa-AR-NH 2 (Catalog # ). The specific activity is >500 pmol/min/μg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived Leu17-Cys470, with Val97Leu substitution
Accession #
N-terminal Sequence
AnalysisLeu17
Structure / Form
Pro form
Predicted Molecular Mass
52 kDa
SDS-PAGE
53-60 kDa, reducing conditions
917-MPB |
| |
Formulation Lyophilized from a 0.2 μm filtered solution in MES, NaCl, CaCl 2, CHAPS, ZnSO 4 and PEG. | ||
Reconstitution Reconstitute at 0.25 mg/mL in 10 mM MES, 0.1 M NaCl, 100 μM CaCl 2, 0.1% CHAPS, 1 μM ZnSO 4 and 0.1% PEG., pH 6.0. | ||
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. | ||
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
Materials
Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 7.5 (TCNB)
Recombinant Human MMP-12 (rhMMP-12) (Catalog # 917-MPB)
p-aminophenylmercuric acetate (APMA) (Sigma, Catalog # A9563), 100 mM stock in DMSO
Substrate MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 (Catalog # ), 2 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Dilute rhMMP-12 to 50 µg/mL in Assay Buffer.
Activate rhMMP-12 by adding APMA to a final concentration of 1 mM and incubating at 37 °C for 24 hours.
Dilute activated rhMMP-12 to 0.4 ng/µL in Assay Buffer.
Dilute Substrate to 20 µM in Assay Buffer.
Load into plate 50 µL of 0.4 ng/µL rhMMP-12, and start the reaction by adding 50 µL of 20 µM Substrate.
Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL of 20 µM Substrate.
Read at excitation and emission wavelengths of 320 nm and 405 nm, respectively, in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) = | Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).
Per Well:
rhMMP-12: 0.020 µg
Substrate: 10 µM
Background: MMP-12
Matrix metalloproteinases (MMPs) are a family of zinc and calcium dependent endopeptidases that collectively degrade the components of the extracellular matrix. MMP-12 (macrophage elastase) consists of the following domains: a pro domain, a catalytic domain containing the zinc-binding site, and a C-terminal hemopexin-like domain. The 54 kDa rhMMP-12 pro form is activated via processing into 45 kDa and 22 kDa active forms (1). MMP-12 is capable of cleaving several substrates in addition to elastin. Macrophage secretion of MMP-12 at sites of inflammation can be induced by cytokines. Given the secretion of MMP12 during an inflammatory response, MMP-12 is involved in many pathologies including vascular disease (2, 3) and cancer (4-6). In particular, MMP12-mediated pathological degradation of the extracellular matrix is a well-established key event in inflammatory-related pulmonary disease (7). For example, overexpression of MMP12 in alveolar macrophages is associated with smoking and emphysema (8) while different MMP-12 variants result in protection against chronic obstructive pulmonary disease (COPD) development (9) or cause increased risk and disease severity (10). MMP-12 has also been shown to translocate into the nucleus of viral-infected cells to directly regulate transcription during an immune response (11).
References:
Shapiro, S.D. et al. (1993) J. Biol. Chem. 268:23824.
Liu, S.L. et al. (2015) Sci. Rep. 5:17189.
Iyer, R.P. et al. (2015) Int. J. Cardiol. 185:198.
Cao, W. et al. (2017) Oncol. Rep. 3:1401.
Klupp, F. et al. (2016) BMC Cancer 16:494.
Chung, I.C. et al. (2014) BMC Cancer 14:348.
Vanderbroucke, R.E. et al. (2011) Eur. Respir. J. 387:1200.
Babusyte, A. et al. (2007) Respir. Res. 8:81.
Hunninghake, G.M. et al. (2009) N. Engl. J. Med. 361:2599.
Mukhopadhyay, S. et al. (2010) J. Allergy Clin. Immunol. 126:70.
Marchant, D.J. et al. (2013) Nature Medicine 20:493.
Long Name:
Matrix Metalloproteinase 12
Entrez Gene IDs:
4321 (Human); 17381 (Mouse)
Alternate Names:
EC 3.4.24; hME; HMEEC 3.4.24.65; Macrophage elastase; macrophage metalloelastase; matrix metallopeptidase 12 (macrophage elastase); matrix metalloproteinase 12 (macrophage elastase); Matrix metalloproteinase-12; ME; MGC138506; MME; MMP12; MMP-12